Effectiveness of the ten- and thirteen-valent pneumococcal conjugate vaccines to prevent serotype 19A invasive pneumococcal disease in Quebec, Canada. A Canadian immunization research network (CIRN) study

In the province of Quebec, Canada, a 2 + 1 dose pneumococcal conjugate vaccine (PCV) program for children was implemented in 2004. PCV7, PCV10, PCV13 and a mixed PCV10/PCV13 schedule were sequentially used without catch-up. The effectiveness of vaccination schedules to prevent serotype 19A invasive...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2024-12, Vol.42 (26), p.126379, Article 126379
Main Authors: Deceuninck, Geneviève, Brousseau, Nicholas, Lefebvre, Brigitte, Quach, Caroline, Tapiero, Bruce, Bui, Yen-Giang, Desjardins, Michael, De Wals, Philippe
Format: Article
Language:English
Subjects:
Age
Antigens
Child, Preschool
Children
Conjugates
Effectiveness
Female
Humans
Immunization
Immunization Programs
Immunization Schedule
Infant
Invasive pneumococcal disease
Laboratories
Male
Pneumococcal conjugated vaccine
Pneumococcal Infections - epidemiology
Pneumococcal Infections - immunology
Pneumococcal Infections - prevention & control
Pneumococcal Vaccines - administration & dosage
Pneumococcal Vaccines - immunology
Public health
Quebec
Quebec - epidemiology
Schedules
Serogroup
Serotype-19A
Streptococcus pneumoniae
Streptococcus pneumoniae - classification
Streptococcus pneumoniae - immunology
Transplants & implants
vaccination
Vaccination - methods
Vaccine effectiveness
Vaccine Efficacy
Vaccines
Vaccines, Conjugate - administration & dosage
Vaccines, Conjugate - immunology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the province of Quebec, Canada, a 2 + 1 dose pneumococcal conjugate vaccine (PCV) program for children was implemented in 2004. PCV7, PCV10, PCV13 and a mixed PCV10/PCV13 schedule were sequentially used without catch-up. The effectiveness of vaccination schedules to prevent serotype 19A invasive pneumococcal disease (IPD) in
ISSN:0264-410X
1873-2518
1873-2518
DOI:10.1016/j.vaccine.2024.126379